Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZMATICS: Azithromycin in Persistent Asthma
NCT00266851Phase 3Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2006
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of azithromycin in asthma, sponsored by University of Wisconsin–Madison. Started Jan 2006; status: completed.
02
Drugs
azithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00266851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266851.